GL1X · GenesisL1 explorer

Research workbench

Structure and function based design of plasmodium-selective proteasome inhibitors

Analyse Structure and function based design of plasmodium-selective proteasome… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5FMG
Type
protein
Length
5,716 residues
Chains
28
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome subunit alpha, putative; Proteasome subunit alpha type 2, putative; Proteasome…
EC
3.4.25.1
UniProt
Q8IAR3, C6KST3, Q8IDG3, Q8IDG2, Q8IBI3, Q8IK90, O77396, Q8I0U7, Q8I6T3, Q8I261, Q8IKC9, Q8IJT1, C0H4E8, Q7K6A9
Ligands
7F1
Pockets
20 · best druggability 0.77

Structure

electron microscopy · 14 distinct chains · 34% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, OProteasome subunit alpha, putative (EC 3.4.25.1)protein21933% helix, 13% strandQ8IAR3
B, PProteasome subunit alpha type 2, putative (EC 3.4.25.1)protein21237% helix, 13% strandC6KST3
C, QProteasome subunit alpha type (EC 3.4.25.1)protein22040% helix, 15% strandQ8IDG3
D, RProteasome subunit alpha type (EC 3.4.25.1)protein21537% helix, 24% strandQ8IDG2
E, SProteasome subunit alpha type (EC 3.4.25.1)protein21734% helix, 17% strandQ8IBI3
F, TProteosome subunit alpha type 1, putativeprotein21934% helix, 16% strandQ8IK90
G, UProteasome component C8, putativeprotein21935% helix, 17% strandO77396
H, VProteasome, putative (EC 3.4.25.1)protein19130% helix, 24% strandQ8I0U7
I, WProteasome subunit beta type (EC 3.4.25.1)protein18633% helix, 28% strandQ8I6T3
J, XBETA3 proteasome subunit, putative (EC 3.4.25.1)protein19132% helix, 24% strandQ8I261
K, YProteasome subunit beta type (EC 3.4.25.1)protein19429% helix, 24% strandQ8IKC9
L, ZProteasome subunit beta type (EC 3.4.25.1)protein18932% helix, 24% strandQ8IJT1
M, aProteasome subunit beta type (EC 3.4.25.1)protein19931% helix, 22% strandC0H4E8
N, bProteasome subunit beta type (EC 3.4.25.1)protein18733% helix, 32% strandQ7K6A9

Ligands and binding sites

  • 7F1 · (2S)-N-[(E,2S)-1-(1H-indol-3-yl)-4-methylsulfonyl-but-3-en-2-yl]-2-[[(2S)-3-(1H-indol-3-yl)-2-(2-morpholin-4-ylethanoylamino)propanoyl]amino]-4-methyl-pentanamide · ligand · 2 copies · chains I, J, W, X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18970.770.8094empty
210170.770.79119empty
311480.750.78116empty
48950.740.7893empty
511630.740.77123empty

Interfaces

70 interfaces between chains.

  • A–G · 1010 Ų buried · 5 hydrogen bonds · protein-protein
  • Q–R · 1005 Ų buried · 12 hydrogen bonds · protein-protein
  • O–U · 1004 Ų buried · 5 hydrogen bonds · protein-protein
  • C–D · 1000 Ų buried · 12 hydrogen bonds · protein-protein
  • F–G · 967 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 5FMG · Structure and function based design of Plasmodium-selective proteasome inhibitors · the same entry in another collection · chain T against T, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.